CRISPR和Cas基因編輯市場：按產品類型、應用、最終用戶和地區分類

據估計，CRISPR和Cas基因市場在2026年的價值為28.5億美元，預計到2033年將達到121.5億美元。預計從2026年到2033年，其複合年成長率將達到23.0%。

叢集的、規律間隔的、短的、回文重複序列（CRISPR-Cas9）是一種獨特的技術，它使遺傳學家和醫學研究人員能夠透過刪除、添加或改變去氧核糖核酸（DNA）序列的片段來編輯基因組。 CRISPR-Cas9系統由兩個主要分子組成，它們負責將突變引入DNA。第一個組成部分是一種名為Cas9的酵素。它就像一把“分子剪刀”，透過在基因組內的特定位置切割DNA雙股，從而添加或移除DNA片段。第二個組成部分稱為引導RNA（gRNA）。它由一段預先設計的短RNA序列（約20個鹼基對）組成，該序列位於一個較長的RNA骨架結構中。骨架部分與DNA結合，而預先設計的序列則「引導」Cas9到達基因組中的相應位點。這確保了Cas9酶在基因組的正確位置進行切割。

市場動態

各大公司正在開發多種遺傳疾病治療方法方案，包括 CRISPR 和 Cas 基因編輯技術。例如，2016 年，總部位於美國的 Addgene 公司開發了 KamiCas9，這是一種具有「自我惰性」功能的 CRISPR-Cas9 基因編輯技術，用於治療中樞神經系統 (CNS) 疾病，例如亨廷頓氏舞蹈症。

CRISPR技術廣泛應用於糖尿病和癌症等疾病的治療研發。因此，這些疾病日益普遍預計將在預測期內推動市場成長。根據國際糖尿病聯盟（IDF）的數據，2019年全球整體約有4.63億成年人（20-79歲）患有糖尿病，預計到2045年，這一數字將增加至7億。此外，65歲以上的老年人中，五分之一患有糖尿病。

此外，根據世界衛生組織（世衛組織）的數據，截至2018年2月，癌症是全球第二大死因，新增病例約1,810萬例，死亡人數達960萬人。世衛組織報告稱，約70%的癌症死亡病例發生在低收入和中等收入國家，癌症約佔全球整體死亡總數的六分之一。

本研究的主要特點：

• 本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、區域前景以及主要參與者採取的競爭策略。
• 本研究基於以下參數分析了全球 CRISPR 和 Cas 基因市場的主要參與者：公司概況、財務表現、產品系列、企業發展區域、分銷策略、關鍵發展和策略以及未來計劃。
• 透過利用本報告中的見解，企業負責人和經營團隊將能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
• 這份全球 CRISPR 和 Cas 基因市場報告旨在為該行業的各類相關人員提供參考，包括投資者、供應商、製造商、經銷商、新參與企業和金融分析師。
• 相關人員可以透過利用 CRISPR 和 Cas 基因市場分析中使用的各種策略矩陣，更輕鬆地做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章：市場動態、監管與趨勢分析

• 市場動態
  • 促進因素
  • 抑制因子
  • 機會
• 近期趨勢
• 併購和合作
• 監管趨勢
• 主要進展
• PEST分析
• 波特的分析

第4章全球CRISPR 與 Cas 基因市場：依產品類型分類，2021-2033 年

• 基於向量的CAS
• 無DNA的Cass
• 其他

第5章全球CRISPR 與 Cas 基因市場：依應用領域分類，2021-2033 年

• 基因組工程
• 疾病模型
• 功能基因體學
• 擊倒/激活
• 其他

第6章全球CRISPR 與 Cas 基因市場：依最終使用者分類，2021-2033 年

• 生物技術和製藥公司
• 學術和政府研究機構
• 受託研究機構

第7章全球CRISPR 與 Cas 基因市場：按地區分類，2021-2033 年

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 義大利
  • 法國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲國家
• 中東
  • GCC
  • 以色列
  • 其他中東國家
• 非洲
  • 北非
  • 中非
  • 南非

第8章 競爭情勢

• 公司簡介
  • Thermo Fisher Scientific Inc.
  • Merck KGaA（Sigma-Aldrich）
  • OriGene Technologies, Inc.
  • New England Biolabs
  • Cellecta, Inc.
  • Agilent Technologies
  • Applied StemCell, Inc.
  • Synthego
  • Genscript
  • Mirus Bio LLC
  • Integrated DNA Technologies, Inc.
  • Mammoth Biosciences, Inc.
• 分析師意見

第9章

• 參考
• 調查方法

Crispr And Cas Gene Market is estimated to be valued at USD 2.85 Bn in 2026 and is expected to reach USD 12.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 23.0% from 2026 to 2033.

Clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 is a unique technology that enables the geneticists and medical researchers to edit parts of the genome by removing, adding or altering sections of the deoxyribonucleic acids (DNA) sequence. The CRISPR-Cas9 system consists of two key molecules that introduce a mutation into the DNA. The first component is an enzyme, which is called as Cas9. This acts as a pair of 'molecular scissors' that can cut the two strands of DNA at a specific location in the genome so that bits of DNA can then be added or removed. The second component is called guide RNA (gRNA). This consists of a small piece of pre-designed RNA sequence (about 20 bases long) located within a longer RNA scaffold. The scaffold part binds to DNA and the pre-designed sequence 'guides' Cas9 to the right part of the genome. This makes sure that the Cas9 enzyme cuts at the right point in the genome.

Market Dynamics

Key players are developing various treatment options, such as CRISPR and CAS genes, for genetic diseases. For instance, in 2016, the U.S.-based company, Addgene, developed the KamiCas9, a version of CRISPR-Cas9 that includes a 'self-inactivating' KamiCas9 system for the editing of central nervous system (CNS) disease genes for the treatment of Huntington's disease.

CRISPR technology is widely used to develop therapeutics for diseases such as diabetes, cancer, etc. Hence, the increasing prevalence of such diseases is expected to drive the market growth over the forecast period. According to The International Diabetes Federation, in 2019, approximately 463 million adults (20-79 years of age) were living with diabetes; by 2045, this will increase to 700 million worldwide. Moreover, one in five of the people who are above 65 years old have diabetes.

Furthermore, according to data findings by the World Health Organization (WHO), in February 2018, cancer was the second-leading cause of death globally, and around 18.1 million new cases and 9.6 million deaths were registered due to cancer. According to the same source, around 70% of deaths from cancer occurred in low and middle income countries, and around one in six deaths across the globe were caused by cancer.

Key features of the study:

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
• It profiles leading players in the global CRISPR and CAS gene market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
• Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Merck KGaA (Sigma-Aldrich), OriGene Technologies, Inc., New England Biolabs, Cellecta, Inc., Agilent Technologies, Inc., Applied StemCell, Inc., Synthego, Genscript, Mirus Bio LLC, Integrated DNA Technologies, Inc., and Mammoth Biosciences, Inc.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
• The global CRISPR and CAS gene market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision making through various strategy matrices used in analyzing the CRISPR and CAS gene market

Market Segmentation

• Global CRISPR and CAS Gene Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
• Vector-based CAS
• DNA-free CAS
• Others
• Global CRISPR and CAS Gene Market, By Application (Revenue, USD Bn, 2021 - 2033)
• Genome Engineering
• Disease Models
• Functional Genomics
• Knockdown/Activation
• Others
• Global CRISPR and CAS Gene Market, By End User (Revenue, USD Bn, 2021 - 2033)
• Biotechnology and Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations
• Global CRISPR and CAS Gene Market, By Region (Revenue, USD Bn, 2021 - 2033)
• North America
• U.S.
• Canada
• Latin America
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• South Africa
• North Africa
• Central Africa
• Company Profiles
• Thermo Fisher Scientific Inc.
• Merck KGaA (Sigma-Aldrich)
• OriGene Technologies, Inc.
• New England Biolabs
• Cellecta, Inc.
• Agilent Technologies, Inc.
• Applied StemCell, Inc.
• Synthego
• Genscript
• Mirus Bio LLC
• Integrated DNA Technologies, Inc.
• Mammoth Biosciences, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Recent Trends
• Merger, Acquisition, and Collaborations
• Regulatory Scenario
• Key Developments
• PEST Analysis
• PORTER's Analysis

4. Global Crispr And Cas Gene Market, By Product Type, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Vector-based Cas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• DNA-free Cas
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends

5. Global Crispr And Cas Gene Market, By Application, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Genome Engineering
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Disease Models
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Functional Genomics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Knockdown/Activation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  • Segment Trends

6. Global Crispr And Cas Gene Market, By End User, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Academic & Government Research Institutes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)

7. Global Crispr And Cas Gene Market, By Region, 2021 - 2033, (US$ Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2021 - 2033
  • Segment Trends
• North America
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Market Size and Forecast, Y-o-Y Growth and By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth and By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2021 - 2033, (US$ Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Latin America
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Market Size and Forecast, Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
  • Market Size and Forecast, By Country, Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
    • North Africa
    • Central Africa
    • South Africa

8. Competitive Landscape

• Company Profiles
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Merck KGaA (Sigma-Aldrich)
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • OriGene Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • New England Biolabs
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Cellecta, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Agilent Technologies
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Applied StemCell, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Synthego
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Genscript
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mirus Bio LLC
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Integrated DNA Technologies, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
  • Mammoth Biosciences, Inc.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Overview
    • Strategies
• Analysts' Views

9. Section

• References
• Research Methodology
• About us and Sales Contact